Goal-Setting in Multiple Sclerosis-Related Spasticity Treated with Botulinum Toxin: The GASEPTOX Study
Spasticity is one of the most disabling symptoms in multiple sclerosis (MS).Botulinum toxin injection (BTI) is a first-line treatment for focal spasticity.There is a lack of evidence of a functional improvement following BTI in MS-related spasticity.To describe goal-setting for BTI in MS, and evaluate the degree of attainment, using goal attainment